DeepMed Research

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Electrical Phrenic Nerve Stimulation in Patients With VIDD

Not Applicable

Recruiting

Conditions: Diaphragms
Phrenic Nerves

Interventions: Device: transcutaneous electrical phrenic nerve stimulation (TEPNS)

First Posted Date: 2024-05-31

Last Posted Date: 2024-11-12

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 40

Registration Number: NCT06436950

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

Not yet recruiting

Conditions: Prostate Cancer

Interventions: Drug: androgen deprivation therapy only
Drug: Darolutamide in addition to androgen deprivation therapy

First Posted Date: 2024-05-30

Last Posted Date: 2024-05-30

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 108

Registration Number: NCT06435702

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Predictive Value of Combining AccuIMR and AccuFFR in Patients With STEMI

Active, not recruiting

Conditions: Prognosis
Acute ST Segment Elevation Myocardial Infarction

Interventions: Diagnostic Test: AccuIMR and AccuFFR

First Posted Date: 2024-05-30

Last Posted Date: 2024-05-30

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 1297

Registration Number: NCT06435728

Locations: 🇨🇳
Peking University Third Hospital, Beijing, China

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Phase 2

Not yet recruiting

Conditions: Cervical Cancer

Interventions: Radiation: radiotherapy
Drug: Nab paclitaxel
Drug: Cisplatin

First Posted Date: 2024-05-23

Last Posted Date: 2024-05-23

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 64

Registration Number: NCT06426056

The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR

Not Applicable

Recruiting

Conditions: Diminished Ovarian Reserve

Interventions: Dietary Supplement: NMN
Other: Placebo

First Posted Date: 2024-05-23

Last Posted Date: 2024-05-23

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 200

Registration Number: NCT06426355

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

Phase 2

Not yet recruiting

Conditions: Advanced Pancreatic Cancer

Interventions: Radiation: Stereotactic body radiation
Drug: Nimotuzumab
Drug: mono-chemotherapy

First Posted Date: 2024-05-20

Last Posted Date: 2024-05-20

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 73

Registration Number: NCT06422156

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China

Recruiting

Conditions: Pre-Eclampsia
Twin Placenta
Twin to Twin Transfusion as Antepartum Condition
Twin Monochorionic Diamniotic Placenta
Twin Dichorionic Diamniotic Placenta
Pre-Term
High Risk Pregnancy
Twin Pregnancy, Antepartum Condition or Complication

First Posted Date: 2024-05-16

Last Posted Date: 2024-05-16

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 2000

Registration Number: NCT06414655

Locations: 🇨🇳
Peking University, Peking, Beijing, China
🇨🇳
First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
🇨🇳
Chongqing Medical University, Chongqing, Chongqing, China

and more 8 locations

Significance of Benign Lymph Node Enlargement in Colorectal Cancer

Completed

Conditions: Colorectal Neoplasms Malignant

Interventions: Other: Observational study, no intervention

First Posted Date: 2024-05-13

Last Posted Date: 2024-05-14

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 2270

Registration Number: NCT06410729

Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy

Not Applicable

Not yet recruiting

Conditions: Diabetic Peripheral Neuropathy

Interventions: Other: needle-free subcutaneous injector for Mecbl
Other: intramuscular injection of Mecbl

First Posted Date: 2024-05-06

Last Posted Date: 2024-05-06

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 30

Registration Number: NCT06400888

Risk Factors, Prognosis and Prediction Models for Placenta Accreta Without Prior Cesarean Section

Recruiting

Conditions: Placenta Accreta Spectrum

First Posted Date: 2024-04-25

Last Posted Date: 2024-04-25

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 200

Registration Number: NCT06383923

Locations: 🇨🇳
Peking University Third Hospital, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy